|

Diabetes Clinical Trials in South Carolina

45 recruiting studies across 23 cities

All Trials in South Carolina

Phase
Trial Phase Location
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)Phase 3Aiken
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusPhase 3Anderson
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 2Anderson
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Phase 3Bluffton
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3Bluffton
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarPhase 3Bluffton
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3Charleston
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/ACharleston
Advanced Fibrosis Detection for MASLD in Primary CareN/ACharleston
Formoterol in DiabetesPhase 2Charleston
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Charleston
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 4Charleston
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaPhase 2/3Charleston
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)—Charlestone
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3Columbia
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Columbia
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Columbia
Dietary Insights and Nutritional Education in Adults on GLP-1 TherapyN/AColumbia
Improving the Collaborative Health of Adult DyadsN/AColumbia
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/AColumbia
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Fort Mill
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3Fort Mill
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinPhase 3Gaffney
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3Gaffney
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies—Gaffney
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3Greenville
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightPhase 2Greenville
CGM for Management of Type 2 Diabetes in PregnancyN/AGreenville
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 4Greenville
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesPhase 2Greenville
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Phase 3Greer
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular EdemaPhase 2Ladson
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyPhase 2Ladson
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3Mauldin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3Mt. Pleasant
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesPhase 3Myrtle Beach
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinPhase 3Myrtle Beach
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3Myrtle Beach
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3Myrtle Beach
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesPhase 3North Charleston
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesPhase 2North Charleston
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2North Charleston
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventPhase 2North Charleston
Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls—Orangeburg
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightPhase 3Spartanburg

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.